The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.
By B. Neel, Haihua Gu, L. Pao. TIBS -Trends in Biochemical Sciences. Regular ed, 2003
1,252 citations recorded by the source corpus.
Subfields: Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/823fffc3afe64cdc15db51f085ccf917389dec66
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Molecular Biology
- M. Karin
- T. Lawrence
- M. McKay
- DK Morrison
- Anica M Wandler
- Crystal M. Botham
- K. Guillemin
- R. Medzhitov
Citations in the corpus
- PD-1 signaling in primary T cells (2009, background): “SHP-1 and SHP-2 are structurally related protein tyrosine phosphatases (PTPs) that each contain two N-terminal SH2 domains, a classic PTP domain and a C-terminal tail that harbor sites for tyrosine phosphorylation (49, 50).”
- Spacing Effect: SHP2 Phosphatase Regulates Resting Intervals Between Learning Trials in Long-Term Memory Induction (2009, neutral): “CSW is a key signaling relay in pathways in C. elegans, Drosophila, Xenopus, and mammals (for review, see Neel et al., 2003 ).”
- Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. (2006, background): “PI3K signaling is inhibited by the PTEN phosphatase that belongs to the protein tyrosine phosphatase (PTP) family; some of its other members, for instance SHIP, SHP1/2, and CD45, are responsible for negative regulation of TK signaling (Neel et al., 2003).”
- Integrating signals from RTKs to ERK/MAPK (2007, background): “Shp-2 has long been known to be a positive regulator of RTK-mediated Ras activation and is a component of many activated RTK complexes, binding to either the receptor or an associated docking protein (Neel et al., 2003).”
- A Transgenic Drosophila Model Demonstrates That the Helicobacter pylori CagA Protein Functions as a Eukaryotic Gab Adaptor (2008, background): “cell growth, differentiation and survival (reviewed in [4]).”
- Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia (2005, neutral): “DH p185 (1-426) p210 (1-902–927) p230 (1–1,176) Y177 Myr GAG BCR F G 1a 1b”